From the COVID-19 vaccine rollout to the GLP-1 revolution, even transformational science has struggled to achieve its potential when the ecosystem wasn’t ready to receive it. The challenge isn’t the data. It’s everything surrounding it — fractured stakeholder attitudes, misaligned payer expectations, societal narratives that haven’t yet caught up with the clinical reality.
The assumption has long been that brilliant science sells itself.
Most organizations begin brand strategy before they've defined the ecosystem. By the time the gap becomes visible, the brand is already written.
The 'Step 0" Imperative: Why Brilliant Science is Failing at Launch
A recorded panel discussion on the pre-strategy thinking that shapes stronger launches and the questions worth asking before your brand plan is written.
